Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467789 · ClinicalTrials.gov registry record · Phase 1
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
A Phase 1 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT03467789 is a Phase 1 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 37 participants.
The verdict
NCT03467789, a Phase 1 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to study 50 patients with multiple Basal Cell Carcinoma (BCC) who will be receiving Photodynamic Therapy (PDT) as treatment for their tumors. This study wants to establish the optimal conditions for treating BCC tumors with PDT. Previous research suggests that taking Vitamin D prior to the start of PDT could help improve the effectiveness of the treatment in eliminating the BCC. Overall, this study will help establish oral Vitamin D3/PDT as a new combination therapy for skin cancer (BCC). Photodynamic Therapy (PDT) is an investigational (experimental) technique that works by combining a photosensitizing topical agent and an intense light source to kill tumor cells. PDT is currently approved for the treatment of BCC in Europe, Canada, and Australia. However, it is experimental in the United States because it is not approved by the Food and Drug Administration (FDA).
Interventions
- DRUG Dietary Vitamin D3 pre-treatment
- RADIATION Photodynamic therapy
- DRUG Serum Maintenance Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2023-01-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03467789
The ClinicalTrials.gov registry entry for NCT03467789 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dietary Vitamin D3 pre-treatment is the first listed.
NCT03467789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03467789 about?
NCT03467789 is a clinical study titled "Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma". The purpose of this study is to study 50 patients with multiple Basal Cell Carcinoma (BCC) who will be receiving Photodynamic Therapy (PDT) as treatment for their tumors. This study wants to establish the optimal conditions for treating BCC tumors with PDT. Previous research suggests that taking Vit...
What is the current status of trial NCT03467789?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2018-10-01. Estimated completion is 2023-01-06.
What interventions are being tested in trial NCT03467789?
The interventions under investigation include: Dietary Vitamin D3 pre-treatment (DRUG), Photodynamic therapy (RADIATION), Serum Maintenance Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT03467789?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.